As technology evolves, more components are integrated into printed circuit boards (PCBs) and the PCB layout increases. Because small defects on signal trace can cause significant damage to the system, PCB surface inspection is one of the most important quality control processes. Owing to the limitations of manual inspection, significant efforts have been made to automate the inspection by utilizing high resolution CCD or CMOS sensors. Despite the advanced sensor technology, setting the pass/fail criteria based on small failure samples has always been challenging in traditional machine vision approaches. To overcome these problems, we propose an advanced PCB inspection system based on a skip-connected convolutional autoencoder. The deep autoencoder model was trained to decode the original non-defect images from the defect images. The decoded images were then compared with the input image to identify the defect location. To overcome the small and imbalanced dataset in the early manufacturing stage, we applied appropriate image augmentation to improve the model training performance. The experimental results reveal that a simple unsupervised autoencoder model delivers promising performance, with a detection rate of up to 98% and a false pass rate below 1.7% for the test data, containing 3900 defect and non-defect images.

With the growth of computing and communication technologies, the information processing paradigm of the healthcare environment is evolving. The patient information is stored electronically, making it convenient to store and retrieve patient information remotely when needed. However, evolving the healthcare systems into smart healthcare environments comes with challenges and additional pressures. Internet of Things (IoT) connects things, such as computing devices, through wired or wireless mediums to form a network. There are numerous security vulnerabilities and risks in the existing IoT-based systems due to the lack of intrinsic security technologies. For example, patient medical data, data privacy, data sharing, and convenience are considered imperative for collecting and storing electronic health records (EHR). However, the traditional IoT-based EHR systems cannot deal with these paradigms because of inconsistent security policies and data access structures. Blockchain (BC) technology is a decentralized and distributed ledger that comes in handy in storing patient data and encountering data integrity and confidentiality challenges. Therefore, it is a viable solution for addressing existing IoT data security and privacy challenges. BC paves a tremendous path to revolutionize traditional IoT systems by enhancing data security, privacy, and transparency. The scientific community has shown a variety of healthcare applications based on artificial intelligence (AI) that improve health diagnosis and monitoring practices. Moreover, technology companies and startups are revolutionizing healthcare with AI and related technologies. This study illustrates the implication of integrated technologies based on BC, IoT, and AI to meet growing healthcare challenges. This research study examines the integration of BC technology with IoT and analyzes the advancements of these innovative paradigms in the healthcare sector. In addition, our research study presents a detailed survey on enabling technologies for the futuristic, intelligent, and secure internet of health things (IoHT). Furthermore, this study comprehensively studies the peculiarities of the IoHT environment and the security, performance, and progression of the enabling technologies. First, the research gaps are identified by mapping security and performance benefits inferred by the BC technologies. Secondly, practical issues related to the integration process of BC and IoT devices are discussed. Third, the healthcare applications integrating IoT, BC, and ML in healthcare environments are discussed. Finally, the research gaps, future directions, and limitations of the enabling technologies are discussed.

Diabetes has recently emerged as a worldwide problem, and diabetic retinopathy is an abnormal state associated with the human retina. Due to the increase in daily screen-related activities of modern human beings, diabetic retinopathy is more prevalent among adults, leading to minor and major blindness. Doctors and clinicians are unable to perform early diagnoses due to the large number of patients. To solve this problem, this study introduces a classification model for retinal images that distinguishes between the various stages of diabetic retinopathy. This work involves deploying deep and densely connected networks for retinal image analysis with training from scratch. Dense connections between the convolutional layers of the network are an essential factor to enhance accuracy owing to the deeper supervision between layers. Another factor is the growth rate that further assists our model in learning more sophisticated feature maps regarding retinal images from every stage of the network. We compute the area under the curve, sensitivity, and specificity, particularly for messidor-2 and EyePACS. Compared to existing approaches, our method achieved better results, with an approximate rise rate of 0.01, 0.03, and 0.01, respectively. Therefore, computer-aided programs can help in diagnostic centers as automated detection systems.

We present the immunoassay of tau proteins (total tau and phosphorylated tau) in human sera using surface plasmon resonance (SPR) fiber sensors. This assay aimed at harvesting the advantages of using both SPR fiber sensors and a blood-based assay to demonstrate label-free point-of-care-testing (POCT) patient-friendly assay in a compact format for the early diagnosis of Alzheimer's disease (AD). For conducting the assay, we used human sera of 40 subjects divided into halves, which were grouped into AD patients and control groups according to a number of neuropsychological tests. We found that on an average, the concentrations of both total tau and phosphorylated tau proteins (all known to be higher in cerebrospinal fluid (CSF) and the brain) turned out to be higher in human sera of AD patients than in controls. The limits of detection of total tau and phosphorylated tau proteins were 2.4 pg mL⁻¹ and 1.6 pg mL⁻¹, respectively. In particular, it was found that the AD group exhibited average concentration of total tau proteins 6-fold higher than the control group, while concentration of phosphorylated tau proteins was 3-fold higher than that of the control. We can attribute this inhomogeneity between both types of tau proteins (in terms of increase of control-to-AD in average concentration) to un-phosphorylated tau proteins being more likely to be produced in blood than phosphorylated tau proteins, which possibly is one of the potential key elements playing an important role in AD progress.

Dynamic consent management allows a data subject to dynamically govern her consent to access her data. Clearly, security and privacy guarantees are vital for the adoption of dynamic consent management systems. In particular, specific data protection guarantees can be required to comply with rules and laws (e.g., the General Data Protection Regulation (GDPR)). Since the primary instantiation of the dynamic consent management systems in the existing literature is towards developing sustainable e-healthcare services, in this paper, we study data protection issues in dynamic consent management systems, identifying crucial security and privacy properties and discussing severe limitations of systems described in the state of the art. We have presented the precise definitions of security and privacy properties that are essential to confirm the robustness of the dynamic consent management systems against diverse adversaries. Finally, under those precise formal definitions of security and privacy, we have proposed the implications of state-of-the-art tools and technologies such as differential privacy, blockchain technologies, zero-knowledge proofs, and cryptographic procedures that can be used to build dynamic consent management systems that are secure and private by design.

Classification and identification of eye diseases using Optical Coherence Tomography (OCT) has been a challenging task and a trending research area in recent years. Accurate classification and detection of different diseases are crucial for effective care management and improving vision outcomes. Current detection methods fall into two main categories: traditional methods and deep learning-based approaches. Traditional approaches rely on machine learning for feature extraction, while deep learning methods utilize data-driven classification model training. In recent years, Deep Learning (DL) and Machine Learning (ML) algorithms have become essential tools, particularly in medical image classification, and are widely used to classify and identify various diseases. However, due to the high spatial similarities in OCT images, accurate classification remains a challenging task. In this paper, we introduce a novel model called “OCTNet” that integrates a deep learning model combining InceptionV3 with a modified multi-scale attention-based spatial attention block to enhance model performance. OCTNet employs an InceptionV3 backbone with a fusion of dual attention modules to construct the proposed architecture. The InceptionV3 model generates rich features from images, capturing both local and global aspects, which are then enhanced by utilizing the modified multi-scale spatial attention block, resulting in a significantly improved feature map. To evaluate the model’s performance, we utilized two state-of-the-art (SOTA) datasets that include images of normal cases, Choroidal Neovascularization (CNV), Drusen, and Diabetic Macular Edema (DME). Through experimentation and simulation, the proposed OCTNet improves the classification accuracy of the InceptionV3 model by 1.3%, yielding higher accuracy than other SOTA models. We also performed an ablation study to demonstrate the effectiveness of the proposed method. The model achieved an overall average accuracy of 99.50% and 99.65% with two different OCT datasets.